openPR Logo
Press release

Conjugated Estrogen Market Assessment and Key Insights Analyzed till 2028 // By key players - Pfizer Inc., Teva Pharmaceuticals USA Inc., Xi'an sgonek biological Technology Co. Ltd.

04-22-2019 09:37 AM CET | Health & Medicine

Press release from: Fact.MR

Conjugated Estrogen Market Assessment and Key Insights

Conjugated estrogen is well-known as an external source and is prescribed as a replacement for female natural hormones. It can be helpful to maintain and balance women health and deal with the symptoms caused by menopause. However, conjugated estrogen is not prescribed to women who have undergone surgical removal of the uterus as estrogen promote abnormal thickening of the lining of the uterus, which can increase the risk of endometrial cancer. But the combination of progestin with estrogen can prevent endometrial cancer. Also, there is a high risk of memory loss and disturbance of thinking process among women over age 65 treated with conjugated estrogen. These factors can retrain the growth of the Conjugated Estrogen Market.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2289

Conjugated estrogen is an active pharmaceutical ingredient that contains a mixture of steroidal and non-steroidal components that are obtained from pregnant mares’ urine. Conjugated estrogen is used as an external source and is prescribed as a replacement of female natural hormones. Estrogen has many well-known effects on the tissues of the body. It causes the growth of the inner lining of uterus, secretion of cervix, development & growth of female sexual organs and maintains the sexual characteristics of females, such as hair growth of underarm and pubic area and countering of body and bone. Menopause is diagnosed when a woman has not had menses for one year. Due to the low production of estrogen in the body, about 85% of women have symptoms such as hot flushes, bone loss, vaginal dryness and shrinkage of tissues. For these symptoms, menopause hormone treatment therapy is the most effective treatment. Conjugated estrogen helps menopausal women treat symptoms such as shrinkage of vaginal tissue, vaginal dryness, hot flashes, bone loss and painful intercourse. However, there are many side effects of conjugated estrogen such as breast swelling, abdominal pain, vaginal bleeding, nausea and mood swings. Patients with heart & kidney diseases should be careful while taking conjugated estrogen as it cause retention of salt & water in the body. Also, a high dose of conjugated estrogen can cause clotting of blood in legs and lungs. Hence, smokers have a high risk of clots and are recommended to quit smoking if they are prescribed conjugated estrogen. Before taking conjugated estrogen, its side effects, dosage, drug interactions, risks and storage should be reviewed properly. 

Menopause is a natural and normal process in women, which occurs due to aging and lowers the function of ovaries and lowers the levels of estrogen and other hormones in the body. The growing prevalence of the female geriatric population and women with menopause is the major factor driving the growth of the conjugated estrogens market over the forecast period. However, limited awareness and negligence about women healthcare services in developing nations and related side effects among women due to menopause hormone treatment therapy are restraining the revenue growth of the global conjugated estrogen market.

Browse Full Report with TOC- https://www.factmr.com/report/2289/conjugated-estrogen-market

The global market for conjugated estrogen is expected to grow at a high rate over the forecast period. Rising population of ageing women with menopause and the rising demand for treatment-related menopause are driving the growth of the conjugated estrogen market. Women with menopause are at a high risk of cardiovascular disease and osteoporosis due to the low production of estrogen in the body. Decreased production of estrogen causes loss of bone density, which in turn causes osteoporosis and fractures in women.

On the basis of geography, the global conjugated estrogen market has been segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the dominant market in the global conjugated estrogen market due to growing prevalence of the geriatric female population with menopause, initiatives towards increasing female health awareness and health coverage. Conjugated estrogen is specifically approved in the United States and Canada for menopause-related problems. Europe is expected to register the second largest share in the global conjugated estrogen market throughout the forecast period, owing to the increasing awareness regarding female healthcare. The conjugated estrogen market in Asia Pacific excluding Japan is expected to grow at a high CAGR due to large population growth and increasing aging population of women and large presence of local players.

Some of the key players in the global conjugated estrogen market include Pfizer Inc., Teva Pharmaceuticals USA, Inc., Xi'an sgonek biological Technology Co., Ltd., Teva Branded Pharm and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2289

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Conjugated Estrogen Market Assessment and Key Insights Analyzed till 2028 // By key players - Pfizer Inc., Teva Pharmaceuticals USA Inc., Xi'an sgonek biological Technology Co. Ltd. here

News-ID: 1712015 • Views:

More Releases from Fact.MR

Remote Control Market Projected to Reach US$ 42.1 Billion by 2034, Growing at a CAGR of 4.8%
Remote Control Market Projected to Reach US$ 42.1 Billion by 2034, Growing at a …
As of right now, estimates place the size of the global remote control market at a 4.8% compound annual growth rate (CAGR) over the following ten years, rising from US$ 26.4 billion in 2024 to US$ 42.1 billion by 2034. Sales of remote controls are expected to increase gradually between 2024 and 2034 as a result of product technical developments and market participants' calculated moves. Businesses have a rare chance to
Global SAP Cloud Platform Services Market is likely to reach a valuation of USD 6.5 Million by 2032
Global SAP Cloud Platform Services Market is likely to reach a valuation of USD …
Fact.MR recently conducted a study on the global SAP cloud platform services market is anticipated to surge from USD 443 million in 2022 to a staggering USD 7,000 million by 2032. This remarkable growth trajectory is projected to unfold at an exhilarating compound annual growth rate (CAGR) of 31% over the period spanning from 2022 to 2032. This analysis delves into pivotal trends shaping the market's growth trajectory. The report elucidates
Mobile Value Added Service Market is projected to rise at a CAGR of 14.9% through 2034
Mobile Value Added Service Market is projected to rise at a CAGR of 14.9% throug …
As per a recent study conducted by Fact.MR, a prominent provider of market research and competitive intelligence, the global Mobile Value Added Service Market is valued at approximately US$ 880.4 million in 2024. Forecasts indicate a robust compound annual growth rate (CAGR) of 14.9% through 2034, with the market anticipated to exceed a valuation of US$ 3,522.6 million by the end of that period. Intense competition among smartphone manufacturers has led
GMP Cell Banking Service Market value is projected to reach US$ 3,123.5 million by 2034
04-23-2024 | Health & Medicine
Fact.MR
GMP Cell Banking Service Market value is projected to reach US$ 3,123.5 million …
According to Fact.MR, a leading provider of market research and competitive intelligence, the global GMP Cell Banking Service Market is anticipated to reach approximately US$ 882.1 million by 2024. Over the period from 2024 to 2034, the market for GMP cell banking services is expected to witness a robust growth rate of 13.7%. The report further forecasts that the market will attain an overall valuation of US$ 3,123.5 million by

All 5 Releases


More Releases for Conjugated

Global Conjugated Monoclonal Antibodies Market Growth Prospects, Future Industry …
Get up to 33% off on ALL market research reports at The Business Research Company's holiday sale; buy now! https://www.thebusinessresearchcompany.com/global-market-reports ‘Conjugated Monoclonal Antibodies Global Market Report 2021 – COVID-19 Growth And Change’ by The Business Research Company is the most comprehensive report available on this market, with analysis of the market’s historic and forecast growth, drivers and restraints causing this, and highlights of the opportunities that companies in the industry can take
Conjugated Monoclonal Antibodies Market Size Analysis, Growth Insights, Opportun …
Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports The global conjugated monoclonal antibodies market is expected to grow from $7.98 billion in 2020 to $8.55 billion in 2021 at a compound annual growth rate (CAGR) of 7.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19
Conjugated Linoleic Acid (CLA) Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Conjugated Linoleic Acid (CLA) market analysis, which studies the Conjugated Linoleic Acid (CLA)'s industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Conjugated Linoleic Acid (CLA) Market 2020-2025” Research Report categorizes the global Conjugated Linoleic Acid (CLA) market by key players, product type, applications and regions,etc. The report also covers the latest
Conjugated Estrogen Market Size, Industry Status and Forecast 2018-2028
Conjugated estrogen is an active pharmaceutical ingredient that contains a mixture of steroidal and non-steroidal components that are obtained from pregnant mares’ urine. Conjugated estrogen is used as an external source and is prescribed as a replacement of female natural hormones. Estrogen has many well-known effects on the tissues of the body. It causes the growth of the inner lining of uterus, secretion of cervix, development & growth of female
Conjugated Linoleic Acid Market Dynamics, Segments and Supply Demand 2018-2026
Conjugated Linoleic Acid Market: Overview Conjugated linoleic acid is a geometric and positional isomer of linoleic acid and is a type of Omega-6 fatty acid, a polyunsaturated fatty acid, derived from mostly sunflower oil and safflower oil. There are 28 different forms of conjugated linoleic acid. Conjugated linoleic acid is naturally present in dairy products and grass-eating animals, such as lamb, grass-fed beef, turkey etc. Unlike other types of Omega-6 fatty
Conjugated Estrogen Market Anticipated to Grow at a Significant Pace by 2029
Conjugated Estrogen Market Overview: Conjugated estrogen is an active pharmaceutical ingredient that contains a mixture of steroidal and non-steroidal components that are obtained from pregnant mares’ urine. Conjugated estrogen is used as an external source and is prescribed as a replacement of female natural hormones. Estrogen has many well-known effects on the tissues of the body. It causes the growth of the inner lining of uterus, secretion of cervix, development &